Aug 8, 2024, 12:52 PM by User Not Found

Bio-IT World | Recursion and Exscientia have entered into a definitive agreement to combine Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities.

Aug 8, 2024, 04:49 AM by

Endor Labs, the leader in software supply chain security, today unveiled two groundbreaking capabilities that fix an expensive and time-consuming problem in the Software Composition Analysis (SCA) market.

Aug 8, 2024, 01:00 AM by User Not Found

Bio-IT World | Singapore’s National Precision Medicine (NPM) program has launched a long-read sequencing project to gain deeper insights into Asian genetic diversity. The program, Precision Health Research, Singapore (PRECISE) has appointed both Oxford Nanopore Technologies (ONT) and PacBio (PacBio) to deliver sequencing.

Aug 7, 2024, 06:36 AM by

Aug 7, 2024, 05:00 AM by User Not Found

Bio-IT World | At last year’s Bio-IT World Conference & Expo, AbbVie won an Innovative Practices Award for their AbbVie R&D Convergence Hub (ARCH). Their data platform is designed to provide access to knowledge in a faster and more automated way, as well as an easier way to extract insights and connect disparate datasets. Today, three years after the launch of ARCH, AbbVie has made great strides in data convergence with the platform.

Aug 6, 2024, 07:40 AM by

Aug 6, 2024, 07:40 AM by

Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.

Aug 6, 2024, 05:00 AM by User Not Found

Bio-IT World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.

Aug 2, 2024, 12:36 PM by User Not Found

Bio-IT World | BioTeam announced its acquisition today by British firm n2 Group. BioTeam will be a US-based, independent business within n2 Group. Financial details have not been disclosed.

Aug 2, 2024, 08:00 AM by

Respondents ages 18 to 65 highlight urgency for medical recognition, scientifically proven interventions, and genetic testing for personalized obesity treatment.

Aug 2, 2024, 08:00 AM by

Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

Aug 2, 2024, 08:00 AM by

Aug 1, 2024, 08:27 AM by

Aug 1, 2024, 05:00 AM by User Not Found

Bio-IT World | Soaring rates of youth prediabetes and diabetes over the past few decades have prompted a multidisciplinary team of experts from the Icahn School of Medicine at Mount Sinai (ISMMS) to create a dataset unifying potentially important clues about how to personalize interventions and devise better prevention strategies.

Jul 31, 2024, 08:22 AM by

Ansa Biotechnologies announced the commercial availability of its Ansa Clonal DNA and Ansa DNA Fragments.

Jul 31, 2024, 08:22 AM by

Phreesia is now available on Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR).

Jul 31, 2024, 08:22 AM by

Jul 30, 2024, 08:27 AM by

Intelliguard, a provider of data integration and RFID-enabled medication management solutions, named Shane Smith its Chief Strategy Officer.

Jul 30, 2024, 08:27 AM by

Jul 30, 2024, 08:27 AM by

Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards in the Innovation category for its eClinical Platform.